3 резултати
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and
FIELD OF THE INVENTION
The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor.
BACKGROUND OF THE INVENTION
Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica